Literature DB >> 21876463

Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome.

Michael P Hunter1, Marianela Nelson, Michael Kurzer, Xuerong Wang, Richard J Kryscio, Elizabeth Head, Graziano Pinna, John P O'Bryan.   

Abstract

Intersectin 1 (ITSN1) is a human chromosome 21 (HSA21) gene product encoding a multidomain scaffold protein that functions in endocytosis, signal transduction, and is implicated in Down's syndrome, Alzheimer's Disease, and potentially other neurodegenerative diseases through activation of c-Jun N-terminal kinase. We report for the first time that ITSN1 proteins are elevated in individuals with Down's syndrome of varying ages. However, ITSN1 levels decreased in aged cases with Down's syndrome with Alzheimer's disease-like neuropathology. Analysis of a novel ITSN1 transgenic mouse reveals that ITSN1 overexpression results in a sex-dependent decrease in locomotor activity. This study reveals a link between overexpression of specific ITSN1 isoforms and behavioral phenotypes and has implications for human neurodegenerative diseases such as Down's syndrome and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21876463      PMCID: PMC3339866          DOI: 10.1097/WNR.0b013e32834ae348

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  24 in total

1.  Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.

Authors:  Eric M Blalock; James W Geddes; Kuey Chu Chen; Nada M Porter; William R Markesbery; Philip W Landfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  Gene expression correlates of neurofibrillary tangles in Alzheimer's disease.

Authors:  Travis Dunckley; Thomas G Beach; Keri E Ramsey; Andrew Grover; Diego Mastroeni; Douglas G Walker; Bonnie J LaFleur; Keith D Coon; Kevin M Brown; Richard Caselli; Walter Kukull; Roger Higdon; Daniel McKeel; John C Morris; Christine Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Neurobiol Aging       Date:  2005-10-19       Impact factor: 4.673

3.  Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

Authors:  Ahmad Salehi; Jean-Dominique Delcroix; Pavel V Belichenko; Ke Zhan; Chengbiao Wu; Janice S Valletta; Ryoko Takimoto-Kimura; Alexander M Kleschevnikov; Kumar Sambamurti; Peter P Chung; Weiming Xia; Angela Villar; William A Campbell; Laura Shapiro Kulnane; Ralph A Nixon; Bruce T Lamb; Charles J Epstein; Gorazd B Stokin; Lawrence S B Goldstein; William C Mobley
Journal:  Neuron       Date:  2006-07-06       Impact factor: 17.173

4.  Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression.

Authors:  Diana T McCloskey; Lynne Turnbull; Philip M Swigart; Alexander C Zambon; Sally Turcato; Shuji Joho; William Grossman; Bruce R Conklin; Paul C Simpson; Anthony J Baker
Journal:  Physiol Genomics       Date:  2005-03-29       Impact factor: 3.107

Review 5.  Intersecting pathways in cell biology.

Authors:  John P O'Bryan
Journal:  Sci Signal       Date:  2010-12-14       Impact factor: 8.192

6.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Alu-splice cloning of human Intersectin (ITSN), a putative multivalent binding protein expressed in proliferating and differentiating neurons and overexpressed in Down syndrome.

Authors:  C Pucharcós; J J Fuentes; C Casas; S de la Luna; S Alcántara; M L Arbonés; E Soriano; X Estivill; M Pritchard
Journal:  Eur J Hum Genet       Date:  1999-09       Impact factor: 4.246

8.  Alprazolam dependence prevented by substituting with the beta-carboline abecarnil.

Authors:  G Pinna; R Galici; H H Schneider; D N Stephens; L Turski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  Control of memory formation through regulated expression of a CaMKII transgene.

Authors:  M Mayford; M E Bach; Y Y Huang; L Wang; R D Hawkins; E R Kandel
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

Review 10.  Targeting JNK for therapeutic benefit: from junk to gold?

Authors:  Anthony M Manning; Roger J Davis
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

View more
  13 in total

Review 1.  Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines.

Authors:  Peter Penzes; Michael E Cahill
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-12

2.  Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.

Authors:  Mustafa Nazir Okur; Angela Russo; John P O'Bryan
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

Review 3.  Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics.

Authors:  Nicole Créau
Journal:  Neural Plast       Date:  2012-07-12       Impact factor: 3.599

Review 4.  Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways.

Authors:  Michael P Hunter; Angela Russo; John P O'Bryan
Journal:  Int J Mol Sci       Date:  2013-04-10       Impact factor: 5.923

5.  The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway.

Authors:  Uma Karthika Rajarajacholan; Subhash Thalappilly; Karl Riabowol
Journal:  PLoS Biol       Date:  2013-03-05       Impact factor: 8.029

Review 6.  Dissecting Alzheimer disease in Down syndrome using mouse models.

Authors:  Xun Yu Choong; Justin L Tosh; Laura J Pulford; Elizabeth M C Fisher
Journal:  Front Behav Neurosci       Date:  2015-10-13       Impact factor: 3.558

7.  Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domain-containing proteins.

Authors:  Olga Novokhatska; Mykola Dergai; Liudmyla Tsyba; Inessa Skrypkina; Valeriy Filonenko; Jacques Moreau; Alla Rynditch
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

8.  The effects of aging on the BTBR mouse model of autism spectrum disorder.

Authors:  Joan M Jasien; Caitlin M Daimon; Rui Wang; Bruce K Shapiro; Bronwen Martin; Stuart Maudsley
Journal:  Front Aging Neurosci       Date:  2014-09-01       Impact factor: 5.750

9.  Altered protein phosphorylation as a resource for potential AD biomarkers.

Authors:  Ana Gabriela Henriques; Thorsten Müller; Joana Machado Oliveira; Marta Cova; Cristóvão B da Cruz E Silva; Odete A B da Cruz E Silva
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

10.  An Endocytic Scaffolding Protein together with Synapsin Regulates Synaptic Vesicle Clustering in the Drosophila Neuromuscular Junction.

Authors:  Åsa M E Winther; Olga Vorontsova; Kathryn A Rees; Tuomas Näreoja; Elena Sopova; Wei Jiao; Oleg Shupliakov
Journal:  J Neurosci       Date:  2015-11-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.